No Data
ASML Reports Q2 Results, Joins Spirit Airlines And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were lower this morning, with the Nasdaq futures falling around 300 points on Wednesday.Shares of ASML Holding N.V. (NASDAQ:ASML) fell in today's pre-market trading following the
Peering Into Structure Therapeutics's Recent Short Interest
Structure Therapeutics's (NYSE:GPCR) short percent of float has risen 31.9% since its last report. The company recently reported that it has 9.29 million shares sold short, which is 19.35% of all
These Are the Weight Loss Drug Stocks With the Most Upside - SA Sentiment Survey
This Weight Loss Stock Is the Best Alternative to Eli Lilly, Novo - SA Sentiment
JMP Securities Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $91
JMP Securities analyst Jonathan Wolleben maintains $Structure Therapeutics(GPCR.US)$ with a buy rating, and maintains the target price at $91.According to TipRanks data, the analyst has a success
Analysts' Top Healthcare Picks: Structure Therapeutics, Inc. Sponsored ADR (GPCR), Armata Pharmaceuticals (ARMP)